Related Experiment Video
Updated: Jul 13, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Feasibility of IA thrombolysis for acute ischemic stroke among anticoagulated patients
Nazli Janjua1, Ammar Alkawi, Alexandros Georgiadis
1Department of Neurology, Long Island College Hospital, 339 Hicks St., Brooklyn, NY 11201, USA. NJanjua@chpnet.com
Background And Purpose:
Limited information exists regarding thrombolysis among anticoagulated acute stroke patients. We present data from three consecutive patients, on active warfarin therapy, treated with intra-arterial reteplase.
Cases:
All patients were screened for the presence of intracranial hemorrhage. Warfarin was reversed with fresh frozen plasma in all patients and cerebral angiography and intra-arterial administration of reteplase was performed. Computed tomographic scans were performed to detect any subsequent intracranial hemorrhage. Ages ranged from 58 to 79 years with initial National Institutes of Health Stroke Scale scores ranging from 12 to 17. Baseline international normalized ratios (INRs) were 1.99-2.25. None of the patients suffered from intracranial hemorrhage following thrombolysis, and two of the patients experienced early neurological improvement.
Conclusion:
Low dose, intra-arterial reteplase following acute reversal of elevated INR is feasible and may offer a potential treatment for patients suffering with acute ischemic stroke while receiving active warfarin treatment.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Transient Ischemic Attack l: Introduction
Ischemic Stroke ll: Pathophysiology

